PPD

PPD is described on its official site as the PPD clinical research business of Thermo Fisher Scientific, a leading global provider of contract research organization (CRO) solutions. It began in 1985 as a one-person consulting firm founded by Fred Eshelman, Pharm. D., and states that it has conducted clinical trials in more than 100 countries. Its offerings include therapeutic expertise across more than 20 therapeutic areas, end-to-end solutions, laboratory services, functional partnership service (FSP) solutions, biotech solutions, and drug development digital solutions.

PPD began in 1985 as a one-person consulting firm founded by Fred Eshelman, Pharm. D. In 1986 it expanded its scope to include development services, and in 1989 it incorporated in North Carolina. In 1995 it expanded to Europe, the Middle East and Africa with the acquisition of Gabbay Group, a CRO in the U.K. In 1996 it had its initial public stock offering, acquired Applied BioScience International (which includes Pharmaco and several European regional drug development companies), and expanded to Latin America with the acquisition of a Brazil-based CRO. In 1997 it began offering drug discovery services and expanded to the Asia-Pacific region with the opening of an office in Australia. In 2001 it declared a one-for-one stock dividend and expanded to the Asia-Pacific region with the opening of an office in Australia. In 2002 it acquired Medical Research Laboratories International, adding central lab services in North America, Europe, the Middle East and Africa, and acquired ProPharma, an Asian-based CRO, which significantly expanded PPD's footprint in Asia-Pacific. The PPD clinical research business of Thermo Fisher Scientific has conducted clinical trials in more than 100 countries.

A leading provider of global clinical research solutions and CRO solutions.

1. 1Global Pharmaceutical Contract Research Organization (CRO) | PPDppd.com
2. 2Our History | PPDppd.com
3. 3Company Resources | PPDppd.com
4. 4Corporate Responsibility | PPDppd.com
5. 5Bitty and Beau’s opens coffee shop in PPDwect.com
6. 6Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Developmentbiospace.com
7. 7PPD begins trading on Nasdaq | WilmingtonBizwilmingtonbiz.com
8. 8PPD collaborates with lupus clinical research experts | WilmingtonBizwilmingtonbiz.com
9. 9PPD files for IPO | WilmingtonBizwilmingtonbiz.com
10. 10PPD launches its initial public offering of 60 million shareswect.com